Olaplex To Buy Purvala Bioscience
(RTTNews) - Olaplex Holdings (OLPX) announced the acquisition of Purvala Bioscience, a Boston-based biotech company. The company noted that this marks the first acquisition from OLAPLEX since the brand launched over ten years ago.
OLAPLEX CEO Amanda Baldwin said: "What we've accomplished to-date has already left such a meaningful impact on our industry, and we believe that with Purvala we have the potential to create the next generation of disruptive science-backed product innovation alongside our patent-protected bond-building technology, Bis-amino."
For More Such Health News, visit rttnews.com.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.